We report a case of a 65-year-old man diagnosed with a ETV6::PDGFRB-translocated MLN, presenting as atypical chronic myeloid leukemia (aCML), who exhibited a brief response with development of resistance to imatinib. Here, ETV6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.